Biggest Gainer at the Opening Bell: Eli Lilly

Upside break out or top?

Trader 3

On Tuesday morning, Eli Lilly (LLY), a developer and producer of pharmaceuticals gapped up over 10%.  

From a technical point of view, on a daily chart, Eli Lilly's stock price has been declining inside of a descending broadening wedge pattern that began to form after price topped out at around $165 on April 24th. The RSI was holding below a bearish trend line since April 24th This morning, the RSI broke above a falling trend line and is currently above 60. Price has reached a critical point within the descending broadening wedge pattern, even though the last few months have shown bearish sentiment, the massive gap up and RSI spike are very bullish signals. If price can hold above the $152.00 support then we will most likely see a retest of the all-time high at $165.00. If price can break $165.00 then price would likely continue advancing making new highs. If price cannot hold above the $152.00 support level, then price will probably fall back towards $144.00 and maybe even lower to touch the lower trend line.       



Source: GAIN Capital, TradingView

More from Equities

Join our live webinars for the latest analysis and trading ideas. Register now

GAIN Capital UK Limited (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.